Searched for
LEVULAN
Explained: What Dr Trump’s 100% bitter tariff pill means for India’s $10 billion pharma export machineThe US has imposed a 100% tariff on branded and patented pharmaceuticals, targeting imports from India’s $10 billion export industry. While...- Sun Pharma shares in focus after USFDA nod for next-gen skin disorder deviceSun Pharma shares: The company announced that the USFDA has approved its enhanced PDT system through the agency’s Real-Time Review Program....
- Sun Pharma Q3 Preview: Sales likely to rise but profit may fall YoYAccording to an ETNow poll, the drugmaker’s consolidated revenue for the quarter ended December is seen rising 12.5% on-year to Rs 11,100 c...
- Sensex hits a fresh 52-week low but these stocks look attractively valuedS Naren of ICICI Prudential MF said the market has not reached a point of maximum pessimism as yet and believes equities would be very attr...
- Sun Pharma plans in-licensing, buyouts to expand speciality businessSpeciality drugs refer to high cost, high complexity medicines, including biologicals, for the treatment of complex or rare conditions. The...
- Sun Pharma arm settles case with Biofrontera, to get USD 22.5 mnIn 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience Gmb...
- Sun Pharma might finally have a prescription for the specialty dreamThe ramp-up in its specialty business over the past year has increasingly turned skeptics into believers. The company has four major produc...
- Sun Pharma arm resolves product promotion investigation with US justice department"DUSA fully cooperated with DOJ in its investigation of a complaint filed by a former employee in September 2016,” Sun Pharmaceutical Indus...
- Contra play? Four of 5 biggest loss makers of Q1 top analyst ‘buy’ listThe five together reported a combined loss of Rs 54,565 crore for June quarter on total sales of Rs 74,310 crore, data compiled from corpor...
- Stock Analysis: One-off blues no reason to give up on Sun PharmaAnalysts have cut their price targets marginally following the hit on bottom line.
- Sun Pharma eyes China, Japan marketsShanghai now plans to steer the company into the specialty business (novel, innovative drugs), and towards expanding markets like China and...
- Sun Pharma's subsidiary files patent infringement suit against German drug maker BiofronteraDUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA and improperly obtained co...
- Reduce Sun Pharma, target Rs 450: IIFLReduce Sun Pharmaceutical Industries Ltd. at a price target of Rs 450.0 .
- How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the USWhile the market opportunities to sell brands appear optimistic, that road is less treaded by Indian companies and obvious challenges can l...
- Sun Pharmaceuticals among bidders for Bayer’s dermatology brandsPrivate equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.
- Looking for larger acquisitions in key markets: Sun PharmaSun Pharmaceutical Industries today said it is looking forward to larger acquisitions as a part of its expansion plans.
- Sun Pharmaceuticals to buy US-based DUSA for $230 million; stock gainsShares of Sun Pharma moved higher in trade of Friday as sentiment turned bullish after it signed a pact to buy US-based DUSA Pharmaceutical...
- Sun Pharma to buy US-based DUSA Pharmaceuticals for $230 millionUnder the terms of agreement, a 100% subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a pr...
- Sun Pharma to acquire US dermatology company DUSA PharmaSun Pharma is to acquire US-based DUSA Pharmaceuticals, Inc, a dermatology company focused on developing and marketing its Levulan (aminole...
- India Inc on shopping spree, announces deals worth Rs 2,850 croreIn major deals worth Rs 2,850 crore, homegrown companies today announced acquisitions of assets from global firms with Sun Pharma buying DU...
Load More
